Replication error phenotype, clinicopathological variables, and patient outcome in Dukes' B stage II (T3,N0,M0) colorectal cancer

Gut

Volumn 46, Issue 2, 2000, Pages 200-204

  Curran, B ^a   Lenehan, K ^a   Mulcahy, H ^b   Tighe, O ^a   Bennett, M A ^a   Kay, E W ^a   O'Donoghue, D P ^b   Leader, M ^a   Croke, D T ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

C Ki ras mutation; c erbB 2; Colon cancer; Microsatellite instability; P53 expression; Replication error phenotype

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COLON CARCINOGENESIS; COLORECTAL CANCER; DNA REPAIR; DNA REPLICATION; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; ONCOGENE C ERB; ONCOGENE K RAS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

AGED; COLORECTAL NEOPLASMS; DNA REPLICATION; FEMALE; GENES, RAS; GENETIC MARKERS; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTOR, ERBB-2; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034105428     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.46.2.200     Document Type: Article

References (43)

1. 1 Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal tumour development. N Engl J Med 1988;319:525-31.
2. 2 Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
3. 3 Aaltonen L. The multistep nature of colon carcinogenesis. Cytokines Cell Mol Ther 1996;2:111-14.
4. 4 Tomlinson I, Ilyas M, Novelli M. Molecular genetics of colon cancer. Cancer Metastasis Rev 1997;16:67-79.
5. 5 Bos JL, Fearon ER, Hamilton SR, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987; 327:293-7.
6. 6 Peltomaki P, Aaltonen LA, Sistonen P, et al. Genetic mapping of a locus predisposing to colorectal cancer. Science 1993;260:810-12.
7. 7 Fishel R, Lescoe MK, Rao MRS, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colorectal cancer. Cell 1993;75:1027-38.
8. 8 Bronner CE, Baker SM, Morrison PT, et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994;368:258-61.
9. 9 Nicolaides NC, Papadopoulos N, Lui B, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994;371:75-80.
10. 10 Meuth M. Patterns of mutation in cancer cells. Cancer Surv 1996;28:33-46.
11. 11 Peltomaki P, de la Chapelle A. Mutations predisposing to hereditary nonpolyposis colorectal cancer. Adv Cancer Res 1997;71:93-119.
12. 12 Lynch HT, Smyrk TC, Watson P, et al. Genetics, natural history, tumor spectrum and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993;104:1535-49.
13. 13 Aaltonen L, Peltomaki P, Leach FS, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993; 260:812-16.
14. 14 Aaltonen L, Peltomaki P, Mecklin JP, et al. Replication errors in benign and malignant tumours from hereditary non-polyposis colorectal cancer patients. Cancer Res 1994; 54:1645-8.
15. 15 Ionov Y, Peinado MA, Malkhosyan S, et al. Ubiquitous somatic mutations in simple repeated sequences reveals a new mechanism for colorectal carcinogenesis. Nature 1993;363:558-61.
16. 16 Lothe RA, Peltomaki P, Meling GI, et al. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 1993;53:5849-52.
17. 17 Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-19.
18. 18 Liu B, Nicolaides NC, Markowitz S, et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 1995;9:48-55.
19. 19 Konishi M, Kikuchi-Yanoshita R, Tanaka K, et al. Molecular nature of colon tumours in hereditary nonpolyposis colon cancer, familial polyposis and sporadic colon cancer. Gastroenterology 1996;111:307-17.
20. 20 Chung DC, Rustgi AK. DNA mismatch repair and cancer. Gastroenterology 1995;109:1685-99.
21. 21 Chapuis PH, Dent OF, Fisher R, et al. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 1985;72:698 702.
22. 22 Bjerkeset T, Morild I, Mork S, et al. Tumour characteristics in colorectal cancer and their relationship to treatment and prognosis. Dis Colon Rectum 1987;30:934-8.
23. 23 Bennett MA, Kay EW, Mulcahy H, et al. Ras and p53 in the prediction of survival in Dukes' B colorectal cancer. J Clin Pathol Mol Pathol 1995;48:M310-15.
24. 24 Breukel C, Tops C, van Leeuwen C, et al. CA repeat polymorphism at the D5S82 locus, proximal to adenomatous polyposis coli (APC). Nucleic Acids Res 1991;19:5804.
25. 25 Spirio L, Joslyn G, Nelson L, et al. A CA-repeat 30-70 kb downstream from the adenomatous polyposis coli (APC) gene. Nucleic Acids Res 1991;19:6348.
26. 26 Hall JM, Friedman L, Guenther C, et al. Closing in on a breast cancer gene on chromosome 17q. Am J Hum Genet 1992;50:1235-42.
27. 27 Jones MH, Nakamura Y. Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism. Genes Chromosomes Cancer 1992;5:89-90.
28. 28 Risinger JI, Boyd J. Dinucleotide repeat polymorphism in the human DCC gene at chromosome 18q21. Hum Mol Genet 1992;1:657.
29. 29 Gyapay G, Morissette J, Vignal A, et al. The 1993-94 Genethon human genetic linkage map. Nat Genet 1994;7:322-5.
30. 30 Kay EW, Mulcahy H, Barry-Walsh C, et al. Cytoplasmic c-erbB-2 protein expression correlates with survival in Dukes' B colorectal carcinoma. Histopathology 1994;25: 455-61.
31. 31 Kay E. MD thesis. University of Dublin, 1996.
32. 32 Ilyas M, Tomlinson IPM, Novelli MR, et al. Clinicopathological features and p53 expression in left-sided sporadic colorectal cancers with and without microsatellite instability. J Pathol 1996;179:370-5.
33. 33 Dubik D, Shiu RPC. Transcriptional regulation of c-myc oncogene expression by estrogen in hormone responsive breast cancer cells. J Biol Chem 1988;263:12705-8.
34. 34 Santos GF, Scott GK, Lee WFM, et al. Estrogn-induced post-transcriptional modulation of c-myc proto-oncogene expression in human breast cancer cells. J Biol Chem 1988; 263:9565-8.
35. 35 Altman DG. Practical statistics for medical research. London: Chapman and Hall, 1991.
36. 36 Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley and Sons, 1980.
37. 37 Farber E. The step-by-step development of epithelial cancer: from phenotype to genotype. Adv Cancer Res 1996; 70:21-48.
38. 38 Toft NJ, Arends MJ. DNA mismatch repair and colorectal cancer. J Pathol 1998;185:123-9.
39. 39 Markowitz S, Wang J, Myeroff L, et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 1995;68:1336-8.
40. 40 Cymes K, Biden K, Simms L, et al. Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet 1996;14:255-7.
41. 41 Cui H, Horon IL, Ohlsson R, et al. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med 1998;4:1276-80.
42. 42 Kim H, Jen J, Vogelstein B, et al. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 1994;145:148-56.
43. 43 Watatani M, Yoshida T, Kuroda K, et al. Allelic loss of chromosome 17p, mutation of the p53 gene and microsatellite instability in right-and left-sided colorectal cancer. Cancer 1996;77:1688-93.